Author: Andrew Johnston MA, Ph.D
Since the height of InsurTech investing and valuations, we’re now experiencing a very healthy inflection point focusing on sustainability, which is reflected by a downturn of speculative investment capital. InsurTechs that focus on clear commercial outcomes are gaining more traction than those trying to offer their technology (only) as a product.
Key Findings for Q2
- Global InsurTech funding fell 34.0% quarter on quarter, from $1.39 billion to $916.71 million.
- Companies raising capital within the early-stage acceleration category raised $134.49M — or 14.7% of total InsurTech funding.
- Q2 23 saw 43 corporate InsurTech investments from (re)insurers, of which 34.9% were directed toward US-based InsurTechs — more than any other country.
